Two dosing regimens that deliver plasma concentrations far above the MIC901

Single and two-dose regimens to 15 days

Dalbavancin mean plasma concentrations versus time in a typical ABSSSI patient (simulation using population pharmacokinetic model)1

1 Xydalba SmPC